Cite
HARVARD Citation
Kawaguchi, K. et al. (n.d.). P-292A phase II study of dose-escalation of regorafenib for patients with previously treated metastatic colorectal cancer – DEREGULATE study - Trial in progress. Annals of oncology. p. . [Online].